Skip to main content
OpenTrials

Clinical trial condition

Communicable Diseases

Explore clinical trials studying Communicable Diseases. Study availability and eligibility vary by location and protocol.

9,173 public trials 550 recruiting studies
Refine in advanced search Browse all conditions

Communicable Diseases trial results

Completed

Efficacy and Safety of Escitalopram for Prevention of Depression Induced by Peg-Interferon in Hepatitis C Patients

NCT00166296

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +19 more
Locations
  • Fundacion Hospital Alcorcon Alcorcón, Spain
  • Hospital Nuestra Señora de Sonsoles Ávila, Spain
  • Hospital Universitari Germans Trias i Pujol Badalona, Spain
  • Hospital del Mar Barcelona, Spain
View all 15 locations
View Trial Details
Completed

Raltegravir Intensification in HIV-infected Patients

NCT00631449

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • San Francisco General Hospital, Clinical Research Center San Francisco, California, United States
  • San Francisco Veterans Affairs Medical Center San Francisco, California, United States
View Trial Details
Completed

Vaccine Therapy in Preventing Human Papillomavirus Infection in Young HIV-Positive Male Patients Who Have Sex With Males

NCT01209325

Conditions
Anal Cancer, Anus Diseases, Anus Neoplasms, +41 more
Locations
  • Moores UCSD Cancer Center La Jolla, California, United States
  • UCLA Clinical AIDS Research and Education (CARE) Center Los Angeles, California, United States
  • Childrens Hospital Los Angeles Los Angeles, California, United States
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
View all 19 locations
View Trial Details
Completed

Short Duration Combination Therapy With Daclatasvir, Asunaprevir, BMS-791325 and Sofosbuvir in Subjects Infected With Chronic Hepatitis-C (FOURward Study)

NCT02175966

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations
  • Inland Empire Liver Foundation Rialto, California, United States
  • Northwestern Memorial Hospital Chicago, Illinois, United States
  • Northwestern University Feinberg School Of Medicine Chicago, Illinois, United States
  • Indiana University Health - University Hospital Indianapolis, Indiana, United States
View Trial Details
Completed

Safety and Efficacy Study in Subjects With Chronic HCV and Underlying Hemophilia

NCT01741545

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations
  • Stanford Boswell Clinic Palo Alto, California, United States
  • Rush University Medical Center Chicago, Illinois, United States
  • Hospital Of The University Of Pennsylvania Philadelphia, Pennsylvania, United States
  • Clinical Research Centers Of America Murray, Utah, United States
View all 32 locations
View Trial Details
Completed

Phase III China GT 1b Interferon (IFN) Intolerant Prev Exclude Dual

NCT01995266

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations
  • Local Institution Beijing, Beijing Municipality, China
  • Local Institution Beijing, Beijing Municipality, China
  • Local Institution Beijing, Beijing Municipality, China
  • Local Institution Beijing, Beijing Municipality, China
View all 38 locations
View Trial Details
Completed

Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials

NCT00695422

Conditions
AIDS-related Kaposi sarcoma, Aids-related Malignancies, Blood-Borne Infections, +33 more
Locations
  • Rebecca and John Moores UCSD Cancer Center La Jolla, California, United States
  • USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States
  • UCLA Clinical AIDS Research and Education (CARE) Center Los Angeles, California, United States
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
View Trial Details
Completed

A Clinical Trial to Evaluate the Efficacy and Safety of Elvitegravir / Cobicistat / Emtricitabine / Tenofovir Alafenamide as a First-line Treatment in Naïve Patients With HIV-1 Infection With Severe Immunosuppression

NCT03693508

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations
  • Hospital Costa del Sol Marbella, Malaga, Spain
  • H. Ramón y Cajal Madrid, Spain
  • H. Clínico San Carlos Madrid, Spain
  • H. Doce de Octubre Madrid, Spain
View Trial Details

Related conditions